Enphys Acquisition Corp. Balance Sheet

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current Assets:
Cash
Deferred offering costs
Prepaid expenses
Due from Sponsor
Other current assets
Total Current Assets
Cash held in Trust Account
Prepaid expenses, non-current
Total Assets
LIABILITIES, REDEEMABLE CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT
Current Liabilities:
Accounts payable and accrued expenses
Accounts payable
Accrued expenses
Accrued offering costs
Note payable - Sponsor
Advance from Sponsor
Total Current Liabilities
Derivative warrant liabilities
Deferred underwriting fees
Total Liabilities
Redeemable Class A Ordinary Shares Subject to Possible Redemption:
Class A ordinary shares, $0.0001 par value, 3,528,693 and 10,198,205 shares issued and outstanding subject to possible redemption at June 30, 2024 and December 31, 2023, respectively.
Shareholders' deficit:
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Ordinary shares
Class A Ordinary Shares
Class B Ordinary Shares
Additional paid-in capital
Accumulated deficit
Total Shareholders' Deficit
Total Liabilities, Redeemable Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit

Comments